Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI Biopharma Biotech
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety
Tolebrutinib: when safety concerns override efficacy signals Tolebrutinib: when safety concerns override efficacy signals
Blog February 24, 2026
Tolebrutinib: when safety concerns override efficacy signals
Biopharma Biotech Clinical trials

Biopharma

When weighing post-approval changes, many health authorities go it alone When weighing post-approval changes, many health authorities go it alone
Blog April 15, 2025
When weighing post-approval changes, many health authorities go it alone
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
This small biotech notched a big win for rare disease patients with a canny market access strategy This small biotech notched a big win for rare disease patients with a canny market access strategy
Blog December 19, 2024
This small biotech notched a big win for rare disease patients with a canny market access strategy
How J&J navigated regulatory approval for a Drug to Watch How J&J navigated regulatory approval for a Drug to Watch
Blog December 17, 2024
How J&J navigated regulatory approval for a Drug to Watch
PBM GPO market share shifts as health plan enrollment continues to churn PBM GPO market share shifts as health plan enrollment continues to churn
Blog December 11, 2024
PBM GPO market share shifts as health plan enrollment continues to churn
Drug combinations: your questions answered Drug combinations: your questions answered
Blog November 19, 2024
Drug combinations: your questions answered
How the U.S. election could impact the healthcare industries How the U.S. election could impact the healthcare industries
Blog October 17, 2024
How the U.S. election could impact the healthcare industries
Increasing your likelihood of success in dealmaking discussions Increasing your likelihood of success in dealmaking discussions
Blog October 17, 2024
Increasing your likelihood of success in dealmaking discussions
Beyond animal testing: the rise of organs-on-chips technology Beyond animal testing: the rise of organs-on-chips technology
Blog October 7, 2024
Beyond animal testing: the rise of organs-on-chips technology
Biotech financing’s rebound: How high will it go? Biotech financing’s rebound: How high will it go?
Blog September 17, 2024
Biotech financing’s rebound: How high will it go?